An Atypical Temporal Sequence for Right Heart Endocarditis: Case Report

  • Paloma Manea
DOI: https://doi.org/10.1532/HSF98.20121119

Abstract

In 2010, an 82-year-old patient received a diagnosis of stage IV chronic obstructive pulmonary disease, ischemic dilated cardiomyopathy, severe secondary pulmonary hypertension, atrial fibrillation with slow ventricular response, and severe tricuspid regurgitation. In December 2011, he was hospitalized for exacerbation of chronic obstructive pulmonary disease. The patient received antibiotics via injections (for 2 weeks through a peripheral venous catheter). In February 2012, he returned to the hospital with congestive heart failure and vascular purpura skin lesions. The echocardiography examination revealed a rupture of cordage afferent to the septal tricuspid valve. Because blood cultures were sterile after 10 days and no vegetation was revealed, the Duke criteria were not fulfilled. In March 2012, the patient returned with congestive heart failure, fatigue, and anorexia. Echocardiography evaluation then revealed attached septal tricuspid valve vegetation. The Duke criteria were now satisfied. The patient received antibiotics at doses recommended for infective endocarditis, with a favorable outcome.

References

Ak K, Adademir T, Isbir S, Arsan S. 2009. Right ventricular mural endocarditis presenting as an isolated apical mass in a non-addict patient with congenital deafness and aphasia. Interact Cardiovasc Thorac Surg 8:498-500.\nBaddour LM, Wilson WR, Bayer AS, et al. 2005. Infective endocarditis: diagnosis, antimicrobial therapy, and management of complications: a statement for healthcare professionals from the Committee on Rheumatic Fever, Endocarditis, and Kawasaki Disease, Council on Cardiovascular Disease in the Young, and the Councils on Clinical Cardiology, Stroke, and Cardiovascular Surgery and Anesthesia, American Heart Association: endorsed by the Infectious Diseases Society of America. Circulation 111:e394-434.\nBaratella MC, Dan M, Fabbri A. 1999. Images in cardiology: Candida endocarditis of the right heart. Heart 82:100.\nBaumgartner H. 2011. Infective endocarditits in adults with congenital heart disease: is it time to change our approach to prophylaxis based on new insights into risk prediction? Eur Heart J 32:1835-7.\nCarozza A, De Santo LS, Romano G, et al. 2006. Infective endocarditis in intravenous drug abusers: patterns of presentation and long-term outcomes of surgical treatment. J Heart Valve Dis 15:125-31.\nCosson S, Kevorkian JP, Milliez P, Beaufils P, Cohen A. 2003. A rare localization in right-sided endocarditis diagnosed by echocardiography: a case report. Cardiovascular Ultrasound 1:10.\nDi Filippo S, Delahaye F, Semiond B, et al. 2006. Current patterns of infective endocarditis in congenital heart disease. Heart 92:1490-5.\nFrontera JA, Grandon JD. 2000. Right-side endocarditis in injection drug users: review of proposed mechanism of pathogenesis, Clin Infect Dis 30:374-9.\nHong-Barco P, O'Toole J, Gerber ML, Domat I, Moquin M, Jackson SC. 1988. Endocarditis due to six entrapped pacemaker leads and concomitant recurrent coronary arteriosclerosis. Ann Thorac Surg 46:97-9.\nMason JW, Rossen RM, Colby T, Hamison DC. 1976. Bacterial endocarditis after cardiac catheterization. Chest 70:293-6.\nMesbahi R, Chaara A, Benomar M. 1991. Infectious endocarditis of the right heart. Arch Mal Coeur Vais 84:355-9.\nMiro JM, del Rio A, Mestres CA. 2002. Infective endocarditis in intravenous drug abusers and HIV-1 infected patients. Infect Dis Clin North Am 16:273-95.\nPerez RE. 1986. Endocarditis with Moraxella-like M-6 after cardiac catheterization. J Clin Microbiol 24:501-2.\nRowley KM, Clubb KS, Smith GJ, Cabin HS. 1984. Right-sided infective endocarditis as a consequence of flow-directed pulmonary-artery catheterization. A clinicopathological study of 55 autopsied patients. N Engl J Med 311:1152-6.\n
Published
2013-06-26
How to Cite
Manea, P. (2013). An Atypical Temporal Sequence for Right Heart Endocarditis: Case Report. The Heart Surgery Forum, 16(3), E144-E146. https://doi.org/10.1532/HSF98.20121119
Issue
Vol 16 No 3 (2013)
Section
Articles

Author Disclosure & Copyright Transfer Agreement

In order to publish the original work of another person(s), The Heart Surgery Forum® must receive an acknowledgment of the Author Agreement and Copyright Transfer Statement transferring to Forum Multimedia Publishing, L.L.C., a subsidiary of Carden Jennings Publishing Co., Ltd. the exclusive rights to print and distribute the author(s) work in all media forms. Failure to check Copyright Transfer agreement box below will delay publication of the manuscript.

A current form follows:

The author(s) hereby transfer(s), assign(s), or otherwise convey(s) all copyright ownership of the manuscript submitted to Forum Multimedia Publishing, LLC (Publisher). The copyright transfer covers the exclusive rights to reproduce and distribute the article and the material contained therein throughout the world in all languages and in all media of expression now known or later developed, including but not limited to reprints, photographic reproduction, microfilm, electronic data processing (including programming, storage, and transmission to other electronic data record(s), or any other reproductions of similar nature), and translations.

However, Publisher grants back to the author(s) the following:

  1. The right to make and distribute copies of all or part of this work for use of the author(s) in teaching;
  2. The right to use, after publication in The Heart Surgery Forum, all or part of the material from this work in a book by the author(s), or in a collection of work by the author(s);
  3. The royalty-free right to make copies of this work for internal distribution within the institution/company that employs the author(s) subject to the provisions below for a work-made-for-hire;
  4. The right to use figures and tables from this work, and up to 250 words of text, for any purpose;
  5. The right to make oral presentations of material from this work.

Publisher reserves the right to grant or refuse permission to third parties to republish all or part of the article or translations thereof. To republish, such third parties must obtain written permission from the Publisher. (This is in accordance with the Copyright Statute, United States Code, Title 17. Exception: If all authors were bona fide officers or employees of the U.S. Government at the time the paper was prepared, the work is a “work of the US Government” (prepared by an officer or employee of the US Government as part of official duties), and therefore is not subject to US copyright; such exception should be indicated on signature lines. If this work was prepared under US Government contract or grant, the US Government may reproduce, royalty-free, all or portions of this work and may authorize others to do so, for official US Government purposes only, if the US Government contract or grant so requires.

I have participated in the conception and design of this work and in the writing of the manuscript and take public responsibility for it. Neither this manuscript nor one with substantially similar content under my authorship has been published, has been submitted for publication elsewhere, or will be submitted for publication elsewhere while under consideration by The Heart Surgery Forum, except as described in an attachment. I have reviewed this manuscript (original version) and approve its submission. If I am listed above as corresponding author, I will provide all authors with information regarding this manuscript and will obtain their approval before submitting any revision. I attest to the validity, accuracy, and legitimacy of the content of the manuscript and understand that Publisher assumes no responsibility for the validity, accuracy, and legitimacy of its content. I warrant that this manuscript is original with me and that I have full power to make this Agreement. I warrant that it contains no matter that is libelous or otherwise unlawful or that invades individual privacy or infringes any copyright or other proprietary right. I agree to indemnify and hold Publisher harmless of and from any claim made against Publisher that relates to or arises out of the publication of the manuscript and agree that this indemnification shall include payment of all costs and expenses relating to the defense of any such claim, including all reasonable attorney’s fees.

I warrant that I have no financial interest in the drugs, devices, or procedures described in the manuscript (except as disclosed in the attached statement).

I state that the institutional Human Subjects Committee and/or the Ethics Committee approved the clinical protocol reported in this manuscript for the use of experimental techniques, drugs, or devices in human subjects and appropriate informed consent documents were utilized.

Furthermore, I state that any and all animals used for experimental purposes received humane care in USDA registered facilities in compliance with the “Principles of Laboratory Animal Care” formulated by the National Society for Medical Research and the “Guide for the Care and Use of Laboratory Animals” prepared by the Institute of Laboratory Animal Resources and published by the National Institutes of Health (NIH Publication No. 85-23, revised 1985).